Nanobiotix SA - ADRNBTX
13F holders, Q3 2024 (September 30)10holders −2
1new positions
3sold out
$5.75avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 3 sold out. The largest holders were Johnson & Johnson ($32.3M), Perceptive Advisors LLC ($3.2M) and BlackRock, Inc. ($1.3M).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $20K |
| Exits | 3 | $14.3M |
All 13F filers, Q2 2024 → Q3 2024: 4,250 shares bought and 2,869,690 shares sold, net −2,865,440 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Johnson & Johnson | 7.57% | No change | 5,623,816 | $32.3M |
| Perceptive Advisors LLC | 0.07% | No change | 555,066 | $3.2M |
| BlackRock, Inc. | 0.00% | — | 228,919 | $1.3M |
| Citigroup Inc. | 0.00% | New | 3,423 | $20K |
| UBS Group AG | 0.00% | No change | 3,100 | $18K |
| GAMMA Investing LLC | 0.00% | Add +40.7% | 2,857 | $16K |
| Bank of America Corp. | 0.00% | Reduce -7.1% | 706 | $4K |
| Barclays PLC | 0.00% | No change | 110 | $633 |
| Rhumbline Advisers | 0.00% | No change | 33 | $189 |
| Morgan Stanley | 0.00% | No change | 2 | $12 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.